WAINUA TRIAL FAILURE
AstraZeneca 'magic' faces rare test after trial failure, share slideAstraZeneca's nerve drug Wainua unexpectedly failed a late-stage heart disease trial. This setback has caused investor concern and impacted...
AstraZeneca shares slide after Ionis-partnered drug fails late-stage heart disease trialAstraZeneca shares fell after Wainua failed a key trial. The drug did not reduce cardiovascular deaths or heart problems. Wainua showed no ...
- Load More